WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cytokinetics earnings were -$894.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CYTK earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$198.8M, down 3.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CYTK reported annual earnings of -$785.0M, with 33.2% growth. The next CYTK earnings date is Nov 4, 2026.

CYTK earnings history

Current Revenue
$67.7M
Current Earnings
-$894.0M
Current Profit Margin
-1,321.1%

CYTK Return on Equity

Insufficient data to display

CYTK Return on Assets

Current Company
-59%
Current Industry
-10.6%
CYTK is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CYTK announces earnings.

CYTK Return on Capital Employed

Current Company
-48.14%
Current Industry
-7.4%
CYTK has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CYTK vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CYTK-$826.65M-$894.00MN/A-$7.22
IBRX-$854.88M-$992.36MN/A-$0.97
PTGX$87.21M$82.91M-34.84%$1.21
CAI$178.10M$105.14MN/A$1.70
ARWR-$181.49M-$319.95MN/A-$2.25
View Top Biotech Stocks

CYTK earnings dates

Next earnings date
Nov 4, 2026

Cytokinetics Earnings Reports & History FAQ

What were Cytokinetics's earnings last quarter?

On CYTK's earnings call on Aug 6, 2026, Cytokinetics (NASDAQ: CYTK) reported Q2 2026 earnings per share (EPS) of -$1.50, up 33.93% year over year. Total CYTK earnings for the quarter were -$198.76 million. In the same quarter last year, Cytokinetics's earnings per share (EPS) was -$1.12.

If you're new to stock investing, here's how to buy Cytokinetics stock.

When does Cytokinetics report earnings?

The next CYTK earnings call is Nov 4, 2026. Add CYTK to your watchlist to be reminded of Cytokinetics's next earnings date.

Is Cytokinetics profitable or losing money?

As of the last Cytokinetics earnings report, Cytokinetics is currently losing money. Cytokinetics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$894.00 million, a 47.45% increase year over year.

What was CYTK's earnings growth in the past year?

As of Cytokinetics's earnings date in Aug 6, 2026, Cytokinetics's earnings has grown year over year. CYTK earnings in the past year totalled -$894.00 million.

What are Cytokinetics's earnings expectations?

The current EPS estimate for Cytokinetics's earnings report in Nov 4, 2026 is -$1.52.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.